Sarepta director Mary Ann Gray to not stand for re-election at 2022 annual meeting

Sarepta Therapeutics, Inc.

Dr. Gray informed the Board on March 31, 2022, of her decision to complete her term at the 2022 annual meeting.
Her departure is not due to any disagreement with Sarepta's operations, policies, or practices.
No replacement has been announced for the Board seat.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mary Ann Gray

director

SRPT · Sarepta Therapeutics, Inc.

Filed: April 5, 2022, 7:59 PM ET

Mary Ann Gray, Ph.D., informed the Board of Directors (the “Board”) of Sarepta Therapeutics, Inc. (the “Company”) that she has elected to not stand for re-election and will complete her term on the Board at the conclusion of the Company’s 2022 annual meeting of stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Mary Ann Gray departed as director at Sarepta Therapeutics, Inc..

Action: elected to not stand for re-election
Role: director

Exact text from the filing

Mary Ann Gray, Ph.D., informed the Board of Directors (the “Board”) of Sarepta Therapeutics, Inc. (the “Company”) that she has elected to not stand for re-election and will complete her term on the Board at the conclusion of the Company’s 2022 annual meeting of stockholders.

View on SEC.gov

Sarepta Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-005381

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.